These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7951110

  • 1. Severe hyperlipidemia following treatment with PUVA for acute skin GVHD.
    Maravić N, Bogdanić V, Aurer I, Nemet D, Labar B.
    Bone Marrow Transplant; 1994 Jul; 14(1):173. PubMed ID: 7951110
    [No Abstract] [Full Text] [Related]

  • 2. [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
    Inamitsu T, Inoue M, Akiyoshi H, Honda K, Shibuya T, Nakayama H, Ueda K.
    Rinsho Ketsueki; 1995 Nov; 36(11):1321-5. PubMed ID: 8691576
    [Abstract] [Full Text] [Related]

  • 3. [Photochemotherapy (PUVA) of acute graft-versus-host disease].
    Reinauer S, Lehmann P, Plewig G, Heyll A, Söhngen D, Hölzle E.
    Hautarzt; 1993 Nov; 44(11):708-12. PubMed ID: 8276589
    [Abstract] [Full Text] [Related]

  • 4. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
    Bonanomi S, Balduzzi A, Tagliabue A, Biagi E, Rovelli A, Corti P, Crippa D, Uderzo C.
    Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
    Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R, Horn T.
    Bone Marrow Transplant; 1996 Jun; 17(6):1061-7. PubMed ID: 8807115
    [Abstract] [Full Text] [Related]

  • 6. PUVA therapy for drug-resistant graft-versus-host disease.
    Atkinson K, Weller P, Ryman W, Biggs J.
    Bone Marrow Transplant; 1986 Dec; 1(2):227-36. PubMed ID: 3502781
    [Abstract] [Full Text] [Related]

  • 7. PUVA therapy for chronic cutaneous graft-vs-host disease.
    Jampel RM, Farmer ER, Vogelsang GB, Wingard J, Santos GW, Morison WL.
    Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
    [Abstract] [Full Text] [Related]

  • 8. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
    Wiesmann A, Weller A, Lischka G, Klingebiel T, Kanz L, Einsele H.
    Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
    [Abstract] [Full Text] [Related]

  • 9. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
    Gerber M, Gmeinhart B, Volc-Platzer B, Kalhs P, Greinix H, Knobler R.
    Bone Marrow Transplant; 1997 Mar; 19(5):517-9. PubMed ID: 9052923
    [Abstract] [Full Text] [Related]

  • 10. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV, Carrizosa Esquivel A, Pulpillo Ruiz A, Herrera Saval A, Conejo-Mir J, Camacho FM.
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [Abstract] [Full Text] [Related]

  • 11. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E.
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [Abstract] [Full Text] [Related]

  • 12. Atypical acute graft-versus-host disease.
    Shin J, Hong W, Song H, Choi G, Kim YC.
    Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG, Alyea EP, Wen PY, Degirolami U, Kesari S.
    J Clin Oncol; 2009 Oct 20; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract] [Full Text] [Related]

  • 16. Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant.
    Kuskonmaz B, Güçer S, Boztepe G, Cetin M, Uckan D.
    Pediatr Transplant; 2007 Mar 20; 11(2):214-6. PubMed ID: 17300504
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM.
    Ned Tijdschr Geneeskd; 2002 Aug 17; 146(33):1542-6. PubMed ID: 12212502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.